NUWENuwellis, Inc.

Nasdaq nuwellis.com


$ 2.68 $ -0.09 (-3.2 %)    

Wednesday, 07-Aug-2024 15:12:16 EDT
QQQ $ 431.72 $ -4.76 (-1.08 %)
DIA $ 387.79 $ -2.19 (-0.56 %)
SPY $ 518.50 $ -3.49 (-0.67 %)
TLT $ 95.87 $ -0.68 (-0.7 %)
GLD $ 220.55 $ -0.15 (-0.07 %)
$ 2.72
$ 3.11
$ 2.56 x 143
-- x --
$ 2.68 - $ 3.13
$ 2.19 - $ 92.75
321,160
na
488,535
$ 0.93
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-08-2024 03-31-2024 10-Q
2 03-11-2024 12-31-2023 10-K
3 11-07-2023 09-30-2023 10-Q
4 08-08-2023 06-30-2023 10-Q
5 05-09-2023 03-31-2023 10-Q
6 03-03-2023 12-31-2022 10-K
7 11-08-2022 09-30-2022 10-Q
8 08-11-2022 06-30-2022 10-Q
9 05-12-2022 03-31-2022 10-Q
10 03-03-2022 12-31-2021 10-K
11 11-10-2021 09-30-2021 10-Q
12 08-12-2021 06-30-2021 10-Q
13 05-13-2021 03-31-2021 10-Q
14 03-25-2021 12-31-2020 10-K
15 11-12-2020 09-30-2020 10-Q
16 08-05-2020 06-30-2020 10-Q
17 05-14-2020 03-31-2020 10-Q
18 03-05-2020 12-31-2019 10-K
19 11-08-2019 09-30-2019 10-Q
20 08-08-2019 06-30-2019 10-Q
21 05-09-2019 03-31-2019 10-Q
22 02-21-2019 12-31-2018 10-K
23 11-07-2018 09-30-2018 10-Q
24 08-09-2018 06-30-2018 10-Q
25 05-10-2018 03-31-2018 10-Q
26 03-22-2018 12-31-2017 10-K
27 11-02-2017 09-30-2017 10-Q
28 08-10-2017 06-30-2017 10-Q
29 05-12-2017 03-31-2017 10-Q
30 03-08-2017 12-31-2016 10-K
31 11-14-2016 09-30-2016 10-Q
32 08-11-2016 06-30-2016 10-Q
33 05-05-2016 03-31-2016 10-Q
34 03-15-2016 12-31-2015 10-K
35 11-05-2015 09-30-2015 10-Q
36 08-05-2015 06-30-2015 10-Q
37 05-07-2015 03-31-2015 10-Q
38 03-20-2015 12-31-2014 10-K
39 10-31-2014 09-30-2014 10-Q
40 08-12-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 why-nuwellis-stock-is-climbing
Why Nuwellis Stock Is Climbing
07/29/2024 17:13:50

Nuwellis shares are trading higher Monday after the company announced Friday that the first pediatric patient has been treated ...

 roth-mkm-initiates-coverage-on-nuwellis-with-buy-rating-announces-price-target-of-17

Roth MKM analyst Jonathan Aschoff initiates coverage on Nuwellis (NASDAQ:NUWE) with a Buy rating and announces Price Target ...

Core News & Articles

QUELIMMUNE, Manufactured For SeaStar Medical And Licensed By Nuwellis, Targets Pediatric AKI Patients With Sepsis Requiring Kid...

 nuwellis-announces-pricing-of-2m-offering-of-469340-shares-of-common-stock-at-a-price-of-424-per-share-priced-at-the-market-under-nasdaq-rules

Nuwellis, Inc. (NASDAQ:NUWE) ("Nuwellis" or the "Company"), a medical technology company focused on transformin...

Core News & Articles

Nuwellis, Inc. (NASDAQ:NUWE), a medical technology company dedicated to transforming the lives of patients suffering from fluid...

 nuwellis-shares-resume-trade
Nuwellis Shares Resume Trade
07/08/2024 20:00:15

 nuwellis-granted-european-patent-ep3873343-for-neonatal-and-pediatric-blood-filtration-system

https://register.epo.org/application?number=EP20776684

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION